T cell metabolism after yellow fever vaccination

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034365

Enrollment

Registered

2024-05-29

Start date

2027-04-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z24

Interventions

Group 1: Healthy donors who have received a vaccination against the yellow fever virus in the vaccination and travel consultation hours of the University Hospital Erlangen at the Institute of Microbio

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Vaccination with the vaccine for which the immune response is to be investigated

Exclusion criteria

Exclusion criteria: a) Incapable of giving consent b) Minors c) Pregnant or breastfeeding women d) Persons who are in a dependent relationship with other study participants or the study investigators

Design outcomes

Primary

Measure	Time frame
Metabolic profile (using mass spectrometric glucose tracing ex vivo), activation profile (using flow cytometry)	—

Secondary

Measure	Time frame
Size and phenotype of antigen-specific T cell responses	—

Countries

Germany

Contacts

Public ContactKilian Schober

Universitätsklinikum Erlangen

kilian.schober@uk-erlangen.de+4991318532644

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026